RE: Investor Meet10 Dec 2021 09:14
Morning steve, agreed, most straight forward and honest interview I have seen. Either way it all boils down to them selling Ruvuma to deliver on their strategy in any meaningful way. Good to see the current AD plant producing revenues and higher EBITA than forecast, but that alone will not make SCIR a profitable company without replicating the model several times over.